These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1724101)

  • 1. The dependence of activation of platelets by a plasminogen activator on the evolution of thrombin activity.
    Torr SR; Eisenberg PR; Sobel BE
    Thromb Res; 1991 Nov; 64(4):435-44. PubMed ID: 1724101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator.
    Penny WF; Ware JA
    Blood; 1992 Jan; 79(1):91-8. PubMed ID: 1530814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of plasmin-induced platelet aggregation.
    Watabe A; Ohta M; Matsuyama N; Mizuno K; el Borai N; Tanimoto T; Kawanishi T; Hayakawa T
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):341-52. PubMed ID: 9261893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative importance of thrombin compared with plasmin-mediated platelet activation in response to plasminogen activation with streptokinase.
    Winters KJ; Santoro SA; Miletich JP; Eisenberg PR
    Circulation; 1991 Oct; 84(4):1552-60. PubMed ID: 1833087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature of interactions between tissue-type plasminogen activator and platelets.
    Torr SR; Winters KJ; Santoro SA; Sobel BE
    Thromb Res; 1990 Jul; 59(2):279-93. PubMed ID: 2146766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.
    Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM
    Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
    Torr-Brown SR; Sobel BE
    Thromb Res; 1993 Dec; 72(5):413-21. PubMed ID: 8303684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ; Eisenberg PR; Abendschein DR
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
    Montrucchio G; Alloatti G; Mariano F; Lupia E; Lucchina PG; Musso E; Emanuelli G; Camussi G
    Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lys- and glu-plasminogen potentiate the inhibitory effect of recombinant tissue plasminogen activator on human platelet aggregation.
    Chen LY; Mehta JL
    Thromb Res; 1994 Jun; 74(6):555-63. PubMed ID: 8091399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
    de Haan J; van Oeveren W
    Thromb Res; 1998 Nov; 92(4):171-9. PubMed ID: 9840026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of thrombin inhibition on the dynamics of thrombolysis and on platelet function during thrombolytic therapy.
    Rudd MA; George D; Johnstone MT; Moore RT; Collins L; Rabbani LE; Loscalzo J
    Circ Res; 1992 Apr; 70(4):829-34. PubMed ID: 1551206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-dependent thrombin generation after in vitro fibrinolytic treatment.
    Aronson DL; Chang P; Kessler CM
    Circulation; 1992 May; 85(5):1706-12. PubMed ID: 1533349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin stimulation of platelets induces plasminogen activation mediated by endogenous urokinase-type plasminogen activator.
    Lenich C; Liu JN; Gurewich V
    Blood; 1997 Nov; 90(9):3579-86. PubMed ID: 9345041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots.
    Prager NA; Abendschein DR; McKenzie CR; Eisenberg PR
    Circulation; 1995 Aug; 92(4):962-7. PubMed ID: 7641380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide.
    Puri RN; Hu CJ; Matsueda R; Umeyama H; Colman RW
    Thromb Res; 1992 Mar; 65(4-5):533-47. PubMed ID: 1535463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries.
    Yao SK; Ober JC; Ferguson JJ; Anderson HV; Maraganore J; Buja LM; Willerson JT
    Circulation; 1992 Dec; 86(6):1993-9. PubMed ID: 1451271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of marked thrombin activity by pharmacologic concentrations of plasminogen activators in nonanticoagulated whole blood.
    Eisenberg PR; Miletich JP
    Thromb Res; 1989 Sep; 55(5):635-43. PubMed ID: 2510363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.